(Q39592383)

English

Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals

scientific article published on 12 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals (English)

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

10

object named as

Patrick Hwu

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Chantale Bernatchez

1

object named as

Chantale Bernatchez

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Marcelo A. Fernández-Viña

6

object named as

Marcelo Fernandez-Vina

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

James Lewis Abbruzzese

9

object named as

James Abbruzzese

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Laurence J. Cooper

8

object named as

Laurence Cooper

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

author name string

Kuichin Zhu

2

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Yufeng Li

3

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Helen Andersson

4

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Constantin Ionnides

5

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Pedro Cano

7

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

David Z Chang

11

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Laszlo G Radvanyi

12

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

language of work or name

0 references

publication date

12 February 2011

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

29

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

16

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

3021-3030

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Regulators of apoptosis: suitable targets for immune therapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

HLA-A0201 positive pancreatic cell lines: new findings and discrepancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

Cloned human TCR from patients with autoimmune disease can respond to two structurally distinct autoantigens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

14 September 2017

The inheritance of Felty's syndrome in a family with several affected members

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

15 June 2018

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

Identification of novel survivin-derived CTL epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

21 August 2018

T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070784

2 December 2018

HLA-B35-restricted immune responses against survivin in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.115

7 January 2021

Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.115

7 January 2021

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.115

7 January 2021

Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.115

7 January 2021

A very high level of crossreactivity is an essential feature of the T-cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.115

7 January 2021

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2011.01.115

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

release_owikqi52s5gghi35rgnawfy4a4

1 reference

https://api.fatcat.wiki/v0/release/owikqi52s5gghi35rgnawfy4a4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39592383&oldid=1854506048"